BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24176581)

  • 41. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    Chiang TY; Fan SY; Jou R
    PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.
    Timire C; Metcalfe JZ; Chirenda J; Scholten JN; Manyame-Murwira B; Ngwenya M; Matambo R; Charambira K; Mutunzi H; Kalisvaart N; Sandy C
    Int J Infect Dis; 2019 Oct; 87():119-125. PubMed ID: 31357057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
    Jabeen K; Shakoor S; Malik F; Hasan R
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
    Al Ammari M; Al Turaiki A; Al Essa M; Kashkary AM; Eltigani SA; Ahmed AE
    Antimicrob Resist Infect Control; 2018; 7():12. PubMed ID: 29387346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Banu S; Rahman MT; Ahmed S; Khatun R; Ferdous SS; Hosen B; Rahman MM; Ahmed T; Cavanaugh JS; Heffelfinger JD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):12-17. PubMed ID: 28157459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
    Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
    Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services.
    Arroyo LH; Yamamura M; Ramos ACV; Campoy LT; Crispim JA; Berra TZ; Alves LS; Alves YM; Dos Santos FL; Souza LLL; Bruce ATI; de Andrade HLP; Bollela VR; Krainski ET; Nunes C; Arcêncio RA
    Trop Med Int Health; 2020 Jul; 25(7):839-849. PubMed ID: 32358845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.
    Tagliani E; Hassan MO; Waberi Y; De Filippo MR; Falzon D; Dean A; Zignol M; Supply P; Abdoulkader MA; Hassangue H; Cirillo DM
    Sci Rep; 2017 Dec; 7(1):17672. PubMed ID: 29247181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
    Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA
    Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
    Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA
    Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
    Gler MT; Macalintal LE; Raymond L; Guilatco R; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2011 May; 15(5):652-6. PubMed ID: 21756517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Second nationwide anti-tuberculosis drug resistance survey in Namibia.
    Ruswa N; Mavhunga F; Roscoe JC; Beukes A; Shipiki E; van Gorkom J; Sawadogo S; Agolory S; Menzies H; Tiruneh D; Makumbi B; Bayer B; Zezai A; Campbell P; Alexander H; Kalisvaart N; Forster N
    Int J Tuberc Lung Dis; 2019 Jul; 23(7):858-864. PubMed ID: 31439119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.